Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. (Q40190639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Alfred L Garfall

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

8

Edward A Stadtmauer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Scott F Huntington

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Brendan M Weiss

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Dan T Vogl

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Patricia A Mangan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jalpa A Doshi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

17 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

published in

The Lancet. Haematology.

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

e408-16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

The 39th David A. Karnofsky Lecture: bench-to-bedside translation of targeted therapies in multiple myeloma

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Pharmacoeconomic implications of lenalidomide maintenance therapy in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Health care costs and resource utilization, including patient burden, associated with novel-agent-based treatment versus other therapies for multiple myeloma: findings using real-world claims data

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Market spiral pricing of cancer drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Cancer drugs in the United States: Justum Pretium--the just price

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Why are cancer drugs so expensive in the United States, and what are the solutions?

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Lenalidomide for multiple myeloma: cost-effectiveness in patients with one prior therapy in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide mai

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

NICE guidance on bortezomib and thalidomide for first-line treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Practical approaches to the use of lenalidomide in multiple myeloma: a canadian consensus

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Health benefits in 2013: moderate premium increases in employer-sponsored plans

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Improving the quality of cancer care in an aging population: recommendations from an IOM report.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Full disclosure--out-of-pocket costs as side effects

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Cost concerns of patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Patient-oncologist cost communication, financial distress, and medication adherence.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Impact of financial burden of cancer on survivors' quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

The development of a financial toxicity patient-reported outcome in cancer: The COST measure

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Drug parity legislation: states, organizations seek to make oral cancer drugs more affordable

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Does comparative effectiveness research promote rationing of cancer care?

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900151-9

7 January 2021

10.1016/S2352-3026(15)00151-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686042%20AND%20SRC:MED&resulttype=core&format=json

release_qdkgcdsyxfhtbbfyp77vt33i3i

3 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qdkgcdsyxfhtbbfyp77vt33i3i

24 November 2022

mapped directly with Wikidata item

1 reference